A combination of PARP and CHK1 inhibitors efficiently antagonizes MYCN-driven tumors
Stefano Di Giulio(Sapienza University of Rome), Marialaura Petroni(Italian Institute of Technology)
Cited by 33
Related Papers
MRE11 inhibition highlights a replication stress-dependent vulnerability of MYCN-driven tumors
|Cell Death and Disease|2018|50
The MRN complex is transcriptionally regulated by MYCN during neural cell proliferation to control replication stress
|Cell Death and Differentiation|2015|36
SMO-M2 mutation does not support cell-autonomous Hedgehog activity in cerebellar granule cell precursors
|Scientific Reports|2019|4